MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data

Go back to MacroGenics Provides Update on Corporate Progress, First Quarter 2024 Financial Results and Interim TAMARACK Phase 2 Study Data
MACROGENICS (NASDAQ: MGNX) Delayed: 4.58 +0.45 (10.90%)
Previous Close $4.13    52 Week High $36.11 
Open $4.01    52 Week Low $14.84 
Day High $4.60    P/E 11.74 
Day Low $4.00    EPS $0.39 
Volume 2,037,999